touchPODCAST

touchMDT for touchIMMUNOLOGY

Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

touchMDT for touchIMMUNOLOGY

Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchMDT for touchIMMUNOLOGY

Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchMDT for touchDERMATOLOGY

Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchMDT for touchDERMATOLOGY

Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchMDT for touchDERMATOLOGY

Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.

The multidisciplinary team

• Dermatologist: Prof. Martin Mertz, Berlin, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

touchFOCUS for touchONCOLOGY

A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice. 

The expert:

• Dr Vadim Koshkin - University of California San Francisco, CA, USA
  

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com

touchIN CONVERSATION for touchIMMUNOLOGY

Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease. 

They respond to questions from the gastroenterology, hepatology and rheumatology clinical communities on:

• Challenges of diagnosing IgG4-related GI disease

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchimmunology.com

touchIN CONVERSATION for touchONCOLOGY

Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com

touchIN CONVERSATION for touchHAEMATOLOGY

Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma.

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchhaematology.com